Traws Pharma (TRAW)
0.76
-0.52 (40.62%)
Upcoming Events
Latest Headlines
Micron, Nebius surge premarket; Traws Pharma tumbles
June 15, 2026 7:27 AM - StreetInsider
Ladenburg Thalmann Downgrades Traws Pharma Inc. (TRAW) to Neutral
June 15, 2026 6:36 AM - StreetInsider
Form 8-K Traws Pharma, Inc. For: Jun 12
June 12, 2026 5:26 PM - SEC Filing
Form ARS Traws Pharma, Inc. For: Dec 31
May 29, 2026 9:05 AM - SEC Filing
Form DEFA14A Traws Pharma, Inc.
May 29, 2026 9:02 AM - SEC Filing
Form DEF 14A Traws Pharma, Inc. For: Jul 08
May 29, 2026 9:00 AM - SEC Filing
Form 8-K Traws Pharma, Inc. For: May 27
May 27, 2026 8:51 AM - SEC Filing
Traws Pharma advances antiviral program for hantavirus and ebola outbreaks
May 27, 2026 8:45 AM - StreetInsider
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
May 27, 2026 8:45 AM - StreetInsider
Form 8-K Traws Pharma, Inc. For: May 22
May 26, 2026 5:10 PM - SEC Filing
Traws Pharma increases ATM offering capacity by $3.1 million
May 22, 2026 8:04 AM - StreetInsider
Form 424B5 Traws Pharma, Inc.
May 22, 2026 8:00 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Traws Pharma Inc. (TRAW)
May 20, 2026 6:48 AM - StreetInsider
Form PRE 14A Traws Pharma, Inc. For: May 19
May 19, 2026 4:02 PM - SEC Filing
Form EFFECT Traws Pharma, Inc.
May 18, 2026 6:04 AM - SEC Filing
Form 424B3 Traws Pharma, Inc.
May 15, 2026 5:15 PM - SEC Filing
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: PERCEPTIVE ADVISORS LLC
May 15, 2026 4:00 PM - SEC Filing
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Squadron Capital Management LLC
May 15, 2026 11:50 AM - SEC Filing
Form 10-Q Traws Pharma, Inc. For: Mar 31
May 15, 2026 7:11 AM - SEC Filing
Form 8-K Traws Pharma, Inc. For: May 15
May 15, 2026 7:06 AM - SEC Filing
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
May 15, 2026 7:00 AM - Globe NewsWire
Form S-3 Traws Pharma, Inc.
May 8, 2026 5:04 PM - SEC Filing
Traws Pharma plans hantavirus treatment development amid cruise ship outbreak
May 8, 2026 7:30 AM - StreetInsider
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
May 8, 2026 7:30 AM - Globe NewsWire
Form SCHEDULE 13D/A Traws Pharma, Inc. Filed by: ORBIMED ADVISORS LLC
May 5, 2026 6:56 PM - SEC Filing
Form 10-K/A Traws Pharma, Inc. For: Dec 31
April 30, 2026 4:37 PM - SEC Filing
Form 4 Traws Pharma, Inc. For: Apr 16 Filed by: ORBIMED ADVISORS LLC
April 28, 2026 9:42 PM - SEC Filing
Form 10-K Traws Pharma, Inc. For: Dec 31
April 15, 2026 4:48 PM - SEC Filing
Form 8-K Traws Pharma, Inc. For: Apr 15
April 15, 2026 4:03 PM - SEC Filing
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
April 15, 2026 4:01 PM - StreetInsider
Traws Pharma secures $60 million financing led by Sirenia Capital
April 15, 2026 8:15 AM - StreetInsider
Traws Pharma Announces Up to $60 Million Private Placement Financing
April 15, 2026 8:15 AM - Globe NewsWire
Form 8-K Traws Pharma, Inc. For: Apr 15
April 15, 2026 8:01 AM - SEC Filing
Form 4 Traws Pharma, Inc. For: Oct 12 Filed by: Parker Charles Nolan
April 8, 2026 2:48 PM - SEC Filing
Form 3 Traws Pharma, Inc. For: Jul 03 Filed by: Parker Charles Nolan
April 8, 2026 2:46 PM - SEC Filing
Form NT 10-K Traws Pharma, Inc. For: Dec 31
March 31, 2026 4:57 PM - SEC Filing
Full Article List
